GlassScriptPhysician profile
Arezo J Karmand
NPI 1366670432
$1,357.32
in general payments reported to CMS, 2019-2025
17 companies · $480 in 2025
The $480 reported for 2025 was more than what 89% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $14.08 · 2021: $37.87 · 2022: $92.31 · 2023: $261 · 2024: $310 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $276.24 | 2022-2024 | Farxiga, Lokelma, Wainua |
| Abbvie INC. | $244.69 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $185.65 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.44 | 2019-2025 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.19 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $63.84 | 2024-2025 | Verquvo |
| Aimmune Therapeutics, INC. | $61.49 | 2025 | Vowst |
| Abiomed | $56.39 | 2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $43.14 | 2023 | Inpefa |
| Edwards Lifesciences Corporation | $31.22 | 2022 | |
| Medtronic, INC. | $30.02 | 2024 | Linq II, Kyphon Express II Kyphopak Tray |
| Allergan, INC. | $27.46 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $19.67 | 2019 | |
| Inspire Medical Systems, INC. | $18.93 | 2025 | Inspire |
| Pfizer INC. | $17.80 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $16.39 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arezo Karmand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.